Advanced Micro Devices
AMD
ASML Holding
ASML
Meta Platforms
META
Cisco
CSCO
Intel
INTC
US Stock MarketDetailed Quotes
RARE Ultragenyx Pharmaceutical
- 43.420
- -0.400-0.91%
Close Dec 27 16:00 ET
- 43.420
- 0.0000.00%
Post 20:01 ET
4.01BMarket Cap-6.84P/E (TTM)
44.070High42.840Low686.52KVolume43.805Open43.820Pre Close29.80MTurnover0.77%Turnover RatioLossP/E (Static)92.34MShares60.37052wk High11.56P/B3.87BFloat Cap37.02052wk Low--Dividend TTM89.11MShs Float179.647Historical High--Div YieldTTM2.81%Amplitude31.520Historical Low43.407Avg Price1Lot Size
Ultragenyx Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 43.16%-67M | 33.74%-76.96M | -21.59%-190.73M | -24.80%-474.81M | 7.13%-83.9M | -23.63%-117.87M | -50.36%-116.16M | -33.48%-156.87M | -12.33%-380.47M | -66.24%-90.34M |
| Net income from continuing operations | 16.37%-133.52M | 17.66%-131.6M | -4.09%-170.68M | 14.25%-606.64M | 18.86%-123.19M | 34.87%-159.65M | -1.05%-159.83M | -7.65%-163.97M | -55.81%-707.42M | -23.99%-151.83M |
| Depreciation and amortization | 21.78%8.76M | 65.30%8.86M | 68.93%8.85M | 42.73%26.01M | 65.79%8.22M | 53.20%7.19M | 19.64%5.36M | 28.08%5.24M | 37.62%18.22M | 40.27%4.96M |
| Other non cash items | -492.03%-10.84M | -40,640.74%-11M | -120.96%-2.29M | -101.10%-1.06M | -214.99%-10.14M | -102.17%-1.83M | -102.76%-27K | 514.32%10.94M | 721.17%96.13M | 877.18%8.82M |
| Change In working capital | 1,001.00%30.83M | 128.50%16.36M | -46.02%-56.02M | -125.07%-15.1M | -39.11%13.3M | -87.37%2.8M | -74.35%7.16M | -228.21%-38.36M | 195.25%60.24M | 5.60%21.85M |
| -Change in receivables | 257.83%9.79M | 114.31%2.16M | -893.14%-24.91M | -88.75%-22.78M | 111.13%1.01M | -204.64%-6.2M | -68.75%-15.08M | -7,700.00%-2.51M | -122.16%-12.07M | -196.25%-9.1M |
| -Change in inventory | 27.89%-2.5M | -149.06%-4.13M | -1,516.00%-2.12M | 28.56%-6.93M | 53.48%-1.96M | -338.31%-3.47M | 48.70%-1.66M | 110.17%150K | -211.23%-9.7M | -324.75%-4.21M |
| -Change in prepaid assets | ---- | ---- | 1,362.62%6.55M | 303.50%15.33M | -138.86%-1.26M | ---- | ---- | -105.69%-519K | 112.87%3.8M | 114.38%3.24M |
| -Change in payables and accrued expense | 44.61%10.82M | 115.00%25.33M | -0.15%-35.54M | -97.28%2.38M | -46.88%18.61M | -32.94%7.48M | -79.48%11.78M | -119.54%-35.49M | 170.61%87.44M | 15.24%35.03M |
| -Change in other working capital | ---- | ---- | ---- | 66.46%-3.1M | ---- | ---- | ---- | ---- | 83.94%-9.24M | -118.47%-3.12M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 43.16%-67M | 33.74%-76.96M | -21.59%-190.73M | -24.80%-474.81M | 7.13%-83.9M | -23.63%-117.87M | -50.36%-116.16M | -33.48%-156.87M | -12.33%-380.47M | -66.24%-90.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -528.50%-275.5M | -39.08%60.56M | -15.16%94.44M | 157.60%168M | 37.64%-107.02M | 139.72%64.3M | 25.58%99.42M | 397.91%111.3M | -49.28%-291.65M | -348.49%-171.6M |
| Net PPE purchase and sale | 56.24%-1.62M | 85.59%-2.01M | 87.17%-3.21M | 61.88%-44.27M | 94.07%-1.6M | 85.81%-3.7M | 54.93%-13.94M | 22.22%-25.03M | -58.87%-116.12M | -68.06%-26.97M |
| Net intangibles purchase and sale | --0 | 0.00%-2.5M | ---10M | 91.67%-2.5M | --0 | --0 | ---2.5M | --0 | ---30M | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---75.03M | --366K |
| Net investment purchase and sale | -500.01%-273.68M | -43.99%65.11M | -21.80%109.71M | 415.55%219.82M | 27.18%-105.15M | 213.57%68.42M | 5.42%116.25M | 467.93%140.29M | 42.59%-69.66M | -268.76%-144.39M |
| Net other investing changes | 52.57%-203K | 89.70%-41K | 47.73%-2.07M | -498.10%-5.05M | 55.13%-271K | -141.81%-428K | -117.49%-398K | -3,392.50%-3.95M | 10.40%-844K | -32.75%-604K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -528.50%-275.5M | -39.08%60.56M | -15.16%94.44M | 157.60%168M | 37.64%-107.02M | 139.72%64.3M | 25.58%99.42M | 397.91%111.3M | -49.28%-291.65M | -348.49%-171.6M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -55.72%11.17M | 1,065.78%384.94M | 91.97%-58K | -22.56%388.14M | 17,466.95%330.61M | -94.87%25.23M | 465.70%33.02M | -144.79%-722K | 322.77%501.21M | -97.80%1.88M |
| Net common stock issuance | -99.53%117K | ---- | ---- | --379.76M | --326.46M | --24.79M | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | 817.87%4.06M | -10.86%4.07M | 92.27%-58K | -22.18%8.42M | 107.60%4.15M | -58.85%442K | -23.63%4.57M | -142.74%-750K | -73.04%10.81M | -71.10%2M |
| Net other financing activities | ---- | ---- | ---- | -100.01%-28K | --0 | --0 | 61.64%-56K | 119.58%28K | 99,773.78%490.4M | 16.20%-119K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -55.72%11.17M | 1,065.78%384.94M | 91.97%-58K | -22.56%388.14M | 17,466.95%330.61M | -94.87%25.23M | 465.70%33.02M | -144.79%-722K | 322.77%501.21M | -97.80%1.88M |
| Net cash flow | ||||||||||
| Beginning cash position | 355.35%490.26M | 33.70%122.37M | 59.45%219.4M | -55.55%137.6M | -80.17%78.61M | -33.83%107.67M | -41.41%91.53M | -55.55%137.6M | -57.37%309.59M | 89.13%396.31M |
| Current changes in cash | -1,068.89%-331.32M | 2,164.18%368.54M | -108.17%-96.35M | 147.59%81.34M | 153.71%139.69M | -112.08%-28.35M | 110.08%16.28M | 69.80%-46.29M | 58.87%-170.91M | -358.92%-260.06M |
| Effect of exchange rate changes | 278.07%1.28M | -376.47%-648K | -421.80%-679K | 142.98%462K | -18.42%1.1M | 33.77%-716K | 89.01%-136K | 295.37%211K | 9.97%-1.08M | 444.90%1.35M |
| End cash Position | 103.82%160.21M | 355.35%490.26M | 33.70%122.37M | 59.45%219.4M | 59.45%219.4M | -80.17%78.61M | -33.83%107.67M | -41.41%91.53M | -55.55%137.6M | -55.55%137.6M |
| Free cash flow | 43.56%-68.61M | 38.56%-81.47M | -12.11%-203.94M | 0.95%-521.57M | 27.11%-85.5M | -0.15%-121.57M | -22.57%-132.6M | -1.22%-181.9M | -27.88%-526.59M | -66.66%-117.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.